Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response - Wikidata - awgldk - TriplyDB

Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response

Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response

http://www.wikidata.org/entity/Q36096051

about

Tumor-Induced Local and Systemic Impact on Blood Vessel Function The new deal: a potential role for secreted vesicles in innate immunity and tumor progression Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal.Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells.Tumor associated macrophages and neutrophils in tumor progression.Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase.Clathrin pit-mediated endocytosis of neutrophil elastase and cathepsin G by cancer cells.Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis.A proposed role for neutrophil extracellular traps in cancer immunoediting.Neutrophil elastase enhances the proliferation and decreases apoptosis of leukemia cells via activation of PI3K/Akt signaling.Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer The immune system and inflammation in breast cancer.Enzyme-activatable imaging probe reveals enhanced neutrophil elastase activity in tumors following photodynamic therapy.Insulin receptor substrate-1 deficiency drives a proinflammatory phenotype in KRAS mutant lung adenocarcinoma.Neutrophil elastase cleavage of the gC1q domain impairs the EMILIN1-α4β1 integrin interaction, cell adhesion and anti-proliferative activity Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase.Neutrophil elastase as a diagnostic marker and therapeutic target in colorectal cancers.PD-L1 expression in triple-negative breast cancer.Protumor and antitumor functions of neutrophil granulocytes.Neutrophils in innate and adaptive immunity.A Strong Neutrophil Elastase Proteolytic Fingerprint Marks the Carcinoma Tumor Proteome.Impact of the immune system and immunotherapy in colorectal cancer.Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells.Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells.Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human.Modulating the innate immune activity in murine tumor microenvironment by a combination of inducer molecules attached to microparticles.Neutral serine proteases of neutrophils.NETs in cancer.One microenvironment does not fit all: heterogeneity beyond cancer cells.Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap.Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target.Roles of neutrophils in cancer growth and progression.Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response.Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis.Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells.

P2860

Q26771958-F769F5A9-F780-4A16-90F9-520527B08DD5 Q28084891-F2A5C36B-1594-4885-8468-632707F15CD5 Q33816141-F60AC6FA-4F7A-4613-BAFD-E3641BC57889 Q34270803-B17F95F6-9BA5-4950-85F0-CB46E27DBB75 Q34306107-339711D6-C04B-4F88-9C9D-BDBC0653008A Q35079179-C6DA8446-E07B-4EF2-A3CA-1CB6E9D1F47B Q35185357-0EA46970-ACCC-4850-A6FB-A1791BF0B334 Q36318875-29300403-9E00-4A81-A060-5AB78E4AC208 Q36417330-46472C59-33AE-413A-8E33-9D1F2910B167 Q36608140-1749C133-4A2B-4D73-A5CF-13991FAC178E Q36660838-1DAB695C-D368-4D9B-82DF-74AC946CF341 Q36817112-745FD234-A1FD-42BC-8083-B3B6383C51C0 Q36903296-E90D2A8B-3015-47D9-8153-E0AC6CFF8BB1 Q37033451-A2588F2B-84D4-4332-942C-A33F64C67EC1 Q37053121-B20789A2-23E8-4DAE-B2AD-6B0E99F3E8C4 Q37161785-9F5C23AC-49E1-4FB8-9E98-CB0279FE2B1E Q37578805-51FFFC24-37CE-4884-8E72-0B0E775E3EA1 Q37582405-D5B621A3-3977-4573-89F5-FC7C2A2BA885 Q37660312-9F3B1C49-5693-4064-AEAC-D15DF2F85F90 Q37724790-4AC9EDD5-06A0-4FEE-A593-8887229CA0EF Q38046098-FC8CA4CD-38A4-4FAB-BC77-673A4D6D81E1 Q38095789-9317B518-113E-4D19-A417-060B398A562C Q38383767-A44C01F6-F27F-4A63-8E3A-AE842C4BA821 Q38398877-8823A2C3-C9C5-40A0-86C9-5110C6C87777 Q38705015-6901B7E8-9DD4-4110-988B-0E68FB5C8D36 Q38774373-7AC7D55C-04D9-47AF-A7A2-91E6D17410CF Q38815765-95AAED16-53DE-4F12-8720-23B975E13A46 Q38868855-0C130D1F-D32B-45BE-A399-AAA9ECF7F395 Q38936537-CF3050F8-DA1F-4FFA-9DD5-36F7004B1228 Q38950988-E9448FE6-8DA7-49E0-9181-AF82C743CD64 Q39011826-59AC3E22-EB39-410D-B56F-74CA48E06562 Q39441390-A229B20F-2273-432C-A50D-A269575F3499 Q49738431-0B5A9D5D-A7EE-47CA-B4C8-50DD6F6CE5A8 Q49973375-430C5224-BD83-4B3F-93F0-3F4724785F1F Q52638390-CACD1BB5-870A-4B70-9896-D556AD9748ED Q53243621-48BFE391-4E56-41F8-93E1-FBD0D222DAB1 Q55008935-68F6A185-C17F-4BDB-BEF8-981D8EBD8BAE

P2860

Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response

http://www.wikidata.org/entity/Q36096051

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Breast cancer cell uptake of t ...... ancer adaptive immune response

@ast

Breast cancer cell uptake of t ...... ancer adaptive immune response

@en

type

label

Breast cancer cell uptake of t ...... ancer adaptive immune response

@ast

Breast cancer cell uptake of t ...... ancer adaptive immune response

@en

prefLabel

Breast cancer cell uptake of t ...... ancer adaptive immune response

@ast

Breast cancer cell uptake of t ...... ancer adaptive immune response

@en

P1433

Q36096051-86CEC469-4A17-4924-9761-880967FD0C9E

P1476

Q36096051-D920EC91-E590-47CB-A657-EEF86AA6B633

P2093

Q36096051-2A1DCC16-00CE-4406-ACC6-67B9411F7CE2

Q36096051-3D069241-2184-4583-BEF6-4B20C299677F

Q36096051-4375C5F7-7B7A-4374-AD5D-78AC2C61BD6E

Q36096051-4935876F-BEFF-46CE-8C7A-FFF063044A0E

Q36096051-54670681-6CCA-4EF1-83C8-965664EA0F98

Q36096051-630CAFBF-ACAF-4ED2-8554-AAC8F50AEF7C

Q36096051-723840CC-75DF-4517-8A6D-E8FF095388C2

Q36096051-7415D525-7220-4310-B4CE-21B52130D566

Q36096051-9D2DB7F5-A93C-44B2-9B47-F8292BDB2CBB

Q36096051-A00BFE25-E962-4780-8723-C96B662CF475

P2860

Q36096051-072073C3-6C75-46B7-B084-F9DF46257EBA

Q36096051-0C510C9A-9935-4112-BF7F-48DF3EC06F90

Q36096051-13AE5095-377C-438A-BBBC-22DA02E8A86B

Q36096051-1AC84958-03AD-436E-8A7D-9523087A8AA5

Q36096051-1B007A97-F325-4848-8371-F170A02E6737

Q36096051-25EDF946-7165-4CA0-825A-D40590752011

Q36096051-27CA5962-5183-4DF1-A69F-4230826EB957

Q36096051-2BBEAF23-79D1-415E-8329-E3D7E45ACC48

Q36096051-2C7578F5-5834-4043-A8C9-2913E7276661

Q36096051-2E93BD8A-C69C-43F7-B555-7C95207B1C32

P304

Q36096051-AE86A8D7-D5EA-4F91-B93E-382BAC1FB425

P31

Q36096051-0F77D5D3-3677-4B52-8447-A1EA26C906F7

P356

Q36096051-84848666-6EC0-4799-AC24-0FE2BAAAE25D

P407

Q36096051-4616ADC8-DE9D-4416-8C41-C8262E705EE5

P433

Q36096051-6595B8FE-3D91-410D-AD0D-19E54065F235

P478

Q36096051-9EFC6561-AEA7-4CFE-8C11-BF8053996BD8

P577

Q36096051-F09C17F8-AE88-4744-8FEE-FC86962ECF4F

P5875

Q36096051-663E95E8-4371-4FCD-913A-4AF8DDC0C16A

P698

Q36096051-F9AE4EDE-0625-4C9B-A5D4-706CF8630106

P921

Q36096051-157E6FC2-6E36-4FA0-A608-DEB668E79D58

P932

Q36096051-50A6CBD6-9902-48C0-94E6-66BE97A04779

P356

0008-5472.CAN-11-4135

P1433

Cancer Research

P1476

Breast cancer cell uptake of t ...... ancer adaptive immune response

@en

P2093

Anne V Philips

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Mittendorf

http://www.w3.org/2001/XMLSchema#string

Gheath Alatrash

http://www.w3.org/2001/XMLSchema#string

Haile Xiao

http://www.w3.org/2001/XMLSchema#string

Jeffrey J Molldrem

http://www.w3.org/2001/XMLSchema#string

Karen Clise-Dwyer

http://www.w3.org/2001/XMLSchema#string

Kathryn Ruisaard

http://www.w3.org/2001/XMLSchema#string

Lisa S St John

http://www.w3.org/2001/XMLSchema#string

Mao Zhang

http://www.w3.org/2001/XMLSchema#string

Na Qiao

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclin E and survival in patients with breast cancer.

Cancer-related inflammation

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth

The role of myeloid cells in the promotion of tumour angiogenesis

The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer.

Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms

A novel interaction between HER2/neu and cyclin E in breast cancer.

Antigen processing by the proteasome.

Identification of the nuclear localization signal in Xenopus cyclin E and analysis of its role in replication and mitosis.

P304

3153-3162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-11-4135

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224916972

http://www.w3.org/2001/XMLSchema#string

P698

22564522

http://www.w3.org/2001/XMLSchema#string

P921

P932

3397251

http://www.w3.org/2001/XMLSchema#string